Pharma-Q Hyoscine Butylbromide 20 mg/1 ml Solution for injection
PDF Leaflet Revision Date: 25 October 2017
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of gastrointestinal spasm.
Dosage (summary)
20 mg IM/IV, 2-3 times daily; max 100 mg/day.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not established safe in pregnancy/lactation.
Key Drug Interactions
- Beta-adrenergic agents
- Central depressants
- Antimuscarinic agents
Contraindications
- Hypersensitivity
- Tachycardia
- Cardiac diseases
- Porphyria
- Myasthenia gravis
- Prostatic enlargement
- Paralytic ileus
- Pyloric stenosis
- Pregnancy
- Breastfeeding
Common side effects
- Anaphylactic shock
- Tachycardia
- Dry mouth
- Giddiness
- Pupil dilation
Counselling Points
- Avoid driving if drowsy
- Avoid alcohol
- Monitor for side effects
Serious warnings
- Risk of ileus in ulcerative colitis
- Increased intra-ocular pressure
- Caution in cardiac conditions
- CNS effects in elderly
Important Disclaimer
The Pharma-Q Hyoscine Butylbromide 20 mg/1 ml Solution for injection professional information leaflet below is the property of Pharma-Q Holdings and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
